Analyst Ratings For Amyris Inc (NASDAQ:AMRS)
Today, HC Wainwright reiterated its Buy rating on Amyris Inc (NASDAQ:AMRS) with a price target of $15.00.
There are 2 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Amyris Inc (NASDAQ:AMRS) is Buy with a consensus target price of $9.6667 per share, a potential 20.38% upside.
Some recent analyst ratings include
- 9/28/2018-Amyris Inc (NASDAQ:AMRS) had its Buy rating reiterated by HC Wainwright with a $15.00 price target
- 11/29/2017-Amyris Inc (NASDAQ:AMRS) had its Hold rating reiterated by Cowen with a $4.00 price target
- 1/11/2017-Amyris Inc (NASDAQ:AMRS) had its Buy rating reiterated by Rodman & Renshaw with a $60.00 price target
- 9/28/2016-Amyris Inc (NASDAQ:AMRS) had its Buy rating reiterated by Singular Research with a $42.00 price target
Recent Insider Trading Activity For Amyris Inc (NASDAQ:AMRS)
Amyris Inc (NASDAQ:AMRS) has insider ownership of 21.80% and institutional ownership of 27.90%.
- On 9/5/2018 Eduardo Alvarez, COO, bought 11,877 with an average share price of $8.45 per share and the total transaction amounting to $100,360.65.
- On 8/22/2018 Kathleen Valiasek, CFO, bought 14,000 with an average share price of $7.20 per share and the total transaction amounting to $100,800.00.
- On 8/20/2018 Frank Kung, Director, sold 3,924,884 with an average share price of $6.22 per share and the total transaction amounting to $24,412,778.48.
- On 8/17/2018 L John Doerr, Director, sold 4,877,386 with an average share price of $6.22 per share and the total transaction amounting to $30,337,340.92.
- On 8/13/2018 Patrick Y Yang, Director, bought 15,000 with an average share price of $7.66 per share and the total transaction amounting to $114,900.00.
- On 8/9/2018 Patrick Y Yang, Director, bought 10,000 with an average share price of $7.71 per share and the total transaction amounting to $77,100.00.
- On 7/16/2018 John Melo, Insider, sold 22,355 with an average share price of $6.61 per share and the total transaction amounting to $147,766.55.
About Amyris Inc (NASDAQ:AMRS)
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Recent Trading Activity for Amyris Inc (NASDAQ:AMRS)
Shares of Amyris Inc closed the previous trading session at 8.03 up +0.21 2.69% with 8.12 shares trading hands.